SHP2 inhibition improves celastrol-induced growth suppression of colorectal cancer
This study aimed to explore novel targets for celastrol sensitization in colorectal cancer (CRC) based on differentially regulated signals in response to high- or low-dose celastrol. Targeting signals were investigated using Western blotting or phosphorylated receptor tyrosine kinase (RTK) arrays. C...
Saved in:
Main Authors: | Linxi Zhang (Author), Xuefei Hu (Author), Qingying Meng (Author), Ye Li (Author), Hao Shen (Author), Yating Fu (Author), Fan Zhang (Author), Jiahui Chen (Author), Wei Zhang (Author), Wenjun Chang (Author), Yamin Pan (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic Suppression of FAK-AKT Signaling Overcomes Resistance to SHP2 Inhibition in Colorectal Carcinoma
by: Ye Li, et al.
Published: (2021) -
Effectively suppressed angiogenesis-mediated retinoblastoma growth using celastrol nanomicelles
by: Zhanrong Li, et al.
Published: (2020) -
Celastrol ameliorates ulcerative colitis-related colorectal cancer in mice via suppressing inflammatory responses and epithelial-mesenchymal transition
by: Lianjie eLin, et al.
Published: (2016) -
Suchilactone inhibits the growth of acute myeloid leukaemia by inactivating SHP2
by: Jingjing Wu, et al.
Published: (2022) -
Novel imidazopyridine suppresses STAT3 activation by targeting SHP-1
by: Jung-Chen Su, et al.
Published: (2018)